Search

Financial results - RBW CLINICAL RESEARCH S.R.L.

0.00
Financial Summary - Rbw Clinical Research S.r.l.
Unique identification code: 45516827
Registration number: J40/1091/2022
Nace: 7219
Sales - Ron
86.517
Net Profit - Ron
42.094
Employees
1
Open Account
Company Rbw Clinical Research S.r.l. with Fiscal Code 45516827 recorded a turnover of 2024 of 86.517, with a net profit of 42.094 and having an average number of employees of 1. The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Rbw Clinical Research S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 54.302 69.319 86.517
Total Income - EUR - - - - - - - 55.244 69.643 86.598
Total Expenses - EUR - - - - - - - 18.177 20.691 43.107
Gross Profit/Loss - EUR - - - - - - - 37.067 48.952 43.491
Net Profit/Loss - EUR - - - - - - - 35.586 40.762 42.094
Employees - - - - - - - 0 0 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 25.5%, from 69.319 euro in the year 2023, to 86.517 euro in 2024. The Net Profit increased by 1.560 euro, from 40.762 euro in 2023, to 42.094 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Rbw Clinical Research S.r.l.

Rating financiar

Financial Rating -
RBW CLINICAL RESEARCH S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Rbw Clinical Research S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Rbw Clinical Research S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Rbw Clinical Research S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Rbw Clinical Research S.r.l. - CUI 45516827

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 0 526 844
Current Assets - - - - - - - 40.145 51.005 67.425
Inventories - - - - - - - 0 81 165
Receivables - - - - - - - 40.068 50.896 48.011
Cash - - - - - - - 77 28 19.248
Shareholders Funds - - - - - - - 35.626 40.810 46.604
Social Capital - - - - - - - 41 40 40
Debts - - - - - - - 4.519 5.599 11.015
Income in Advance - - - - - - - 0 5.278 10.821
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7219 - 7219"
CAEN Financial Year 7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 67.425 euro in 2024 which includes Inventories of 165 euro, Receivables of 48.011 euro and cash availability of 19.248 euro.
The company's Equity was valued at 46.604 euro, while total Liabilities amounted to 11.015 euro. Equity increased by 6.022 euro, from 40.810 euro in 2023, to 46.604 in 2024. The Debt Ratio was 16.1% in the year 2024.
Monitors the Company

Risk Reports Prices

Reviews - Rbw Clinical Research S.r.l.

Comments - Rbw Clinical Research S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.